Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity

Cancer Letters

Volumn 367, Issue 2, 2015, Pages 93-102

  Petiwala, Sakina M ^a   Johnson, Jeremy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Carnosic acid; Carnosol; Chemoprevention; Nrf2; Rosemary; Rosmanol

Indexed keywords

ARSENIC TRIOXIDE; CARNOSIC ACID; CARNOSOL; CASPASE 3; CASPASE 9; DITERPENE; FAS ANTIGEN; FAS LIGAND; FOOD PRESERVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 8; PROTEIN BCL 2; PROTEIN BID; ROSMANOL; ROSMARINUS OFFICINALIS EXTRACT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; AREA UNDER THE CURVE; AUTOPHAGY; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; DISEASE MODEL; DOWN REGULATION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; ENZYME ACTIVATION; EUROPEAN UNION; FIBROSARCOMA; FOOD AND DRUG ADMINISTRATION; FOOD COMPOSITION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAXIMUM PLASMA CONCENTRATION; MEDITERRANEAN DIET; METASTASIS INHIBITION; MOUTH CARCINOMA; MYELOID LEUKEMIA; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; ROSEMARY; SHORT SURVEY; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SKIN CANCER; TIME TO MAXIMUM PLASMA CONCENTRATION; UNITED STATES; ANIMAL; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MEDICINAL PLANT; METABOLISM; NEOPLASMS; PATHOLOGY; PHYTOTHERAPY; ROSMARINUS;

ANIMALIA; ROSMARINUS OFFICINALIS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DITERPENES; DITERPENES, ABIETANE; HUMANS; NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; ROSMARINUS; SIGNAL TRANSDUCTION;

EID: 84939271452     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.07.005     Document Type: Review

References (74)

1. al-Sereiti M.R., Abu-Amer K.M., Sen P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J. Exp. Biol 1999, 37:124-130.
2. Bozin B., Mimica-Dukic N., Samojlik I., Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J. Agric. Food Chem 2007, 55:7879-7885.
3. Peng C.H., Su J.D., Chyau C.C., Sung T.Y., Ho S.S., Peng C.C., et al. Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Biosci. Biotechnol. Biochem 2007, 71:2223-2232.
4. Peng Y., Yuan J., Liu F., Ye J. Determination of active components in rosemary by capillary electrophoresis with electrochemical detection. J. Pharm. Biomed. Anal 2005, 39:431-437.
5. Tai J., Cheung S., Wu M., Hasman D. Antiproliferation effect of rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Phytomedicine 2012, 19:436-443.
6. Valdes A., Garcia-Canas V., Rocamora-Reverte L., Gomez-Martinez A., Ferragut J.A., Cifuentes A. Effect of rosemary polyphenols on human colon cancer cells: transcriptomic profiling and functional enrichment analysis. Genes Nutr 2013, 8:43-60.
7. Petiwala S.M., Puthenveetil A.G., Johnson J.J. Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer. Front. Pharmacol 2013, 4:29.
8. Gonzalez-Vallinas M., Molina S., Vicente G., Sanchez-Martinez R., Vargas T., Garcia-Risco M.R., et al. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells. Electrophoresis 2014, 35:1719-1727.
9. Singletary K., MacDonald C., Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett 1996, 104:43-48.
10. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Lou Y.R., Stauber K., et al. Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 1994, 54:701-708.
11. Petiwala S.M., Berhe S., Li G., Puthenveetil A.G., Rahman O., Nonn L., et al. Rosemary (Rosmarinus officinalis) extract modulates CHOP/GADD153 to promote androgen receptor degradation and decreases xenograft tumor growth. PLoS ONE 2014, 9:e89772.
12. Yan M., Li G., Petiwala S.M., Householter E., Johnson J.J. Standardized rosemary (Rosmarinus officinalis) extract induces Nrf2/sestrin-2 pathway in colon cancer cells. J. Funct. Foods 2015, 13:137-147.
13. Parikh N.R., Mandal A., Bhatia D., Siveen K.S., Sethi G., Bishayee A. Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives. Phytochem. Rev 2014, 13:793-810.
14. Rabi T., Bishayee A. Terpenoids and breast cancer chemoprevention. Breast Cancer Res. Treat 2009, 115:223-239.
15. Thoppil R.J., Bishayee A. Terpenoids as potential chemopreventive and therapeutic agents in liver cancer. World J. Hepatol 2011, 3:228-249.
16. Shanmugam M.K., Dai X., Kumar A.P., Tan B.K., Sethi G., Bishayee A. Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. Biochem. Pharmacol 2013, 85:1579-1587.
17. Aruoma O.I., Halliwell B., Aeschbach R., Loligers J. Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica 1992, 22:257-268.
18. Mulinacci N., Innocenti M., Bellumori M., Giaccherini C., Martini V., Michelozzi M. Storage method, drying processes and extraction procedures strongly affect the phenolic fraction of rosemary leaves: an HPLC/DAD/MS study. Talanta 2011, 85:167-176.
19. Wenkert E., Fuchs A., McChesney J.D. Chemical artifacts from the family Labiatae. J. Org. Chem 1965, 30:2931-2934.
20. Thorsen M.A., Hildebrandt K.S. Quantitative determination of phenolic diterpenes in rosemary extracts. Aspects of accurate quantification. J. Chromatogr. A 2003, 995:119-125.
21. Yesil-Celiktas O., Sevimli C., Bedir E., Vardar-Sukan F. Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum. Nutr 2010, 65:158-163.
22. Tsai C.W., Lin C.Y., Lin H.H., Chen J.H. Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells. Neurochem. Res 2011, 36:2442-2451.
23. Steiner M., Priel I., Giat J., Levy J., Sharoni Y., Danilenko M. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Nutr. Cancer 2001, 41:135-144.
24. Wang R., Li H., Guo G., Li X., Yu X., Wang J., et al. Augmentation by carnosic acid of apoptosis in human leukaemia cells induced by arsenic trioxide via upregulation of the tumour suppressor PTEN. J. Int. Med. Res 2008, 36:682-690.
25. Wang R., Cong W.H., Guo G., Li X.X., Chen X.L., Yu X.N., et al. Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway. Chin. J. Integr. Med 2012, 18:934-941.
26. Einbond L.S., Wu H.A., Kashiwazaki R., He K., Roller M., Su T., et al. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin. Fitoterapia 2012, 83:1160-1168.
27. Kar S., Palit S., Ball W.B., Das P.K. Carnosic acid modulates Akt/IKK/NF-kappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 2012, 17:735-747.
28. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic. Biol. Med 2010, 49:1603-1616.
29. Barni M.V., Carlini M.J., Cafferata E.G., Puricelli L., Moreno S. Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells. Oncol. Rep 2012, 27:1041-1048.
30. Visanji J.M., Thompson D.G., Padfield P.J. Induction of G2/M phase cell cycle arrest by carnosol and carnosic acid is associated with alteration of cyclin A and cyclin B1 levels. Cancer Lett 2006, 237:130-136.
31. Valdes A., Garcia-Canas V., Simo C., Ibanez C., Micol V., Ferragut J.A., et al. Comprehensive foodomics study on the mechanisms operating at various molecular levels in cancer cells in response to individual rosemary polyphenols. Anal. Chem 2014, 86:9807-9815.
32. Capozzi F., Bordoni A. Foodomics: a new comprehensive approach to food and nutrition. Genes Nutr 2013, 8:1-4.
33. Kim Y.J., Kim J.S., Seo Y.R., Park J.H., Choi M.S., Sung M.K. Carnosic acid suppresses colon tumor formation in association with antiadipogenic activity. Mol. Nutr. Food Res 2014, 58:2274-2285.
34. Gonzalez-Vallinas M., Molina S., Vicente G., Zarza V., Martin-Hernandez R., Garcia-Risco M.R., et al. Expression of microRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of Rosemary diterpenes in colon and pancreatic cancer. PLoS ONE 2014, 9:e98556.
35. Min K.J., Jung K.J., Kwon T.K. Carnosic acid induces apoptosis through reactive oxygen species-mediated endoplasmic reticulum stress induction in human renal carcinoma caki cells. J. Cancer Prev 2014, 19:170-178.
36. Gao Q., Liu H., Yao Y., Geng L., Zhang X., Jiang L., et al. Carnosic acid induces autophagic cell death through inhibition of the Akt/mTOR pathway in human hepatoma cells. J. Appl. Toxicol 2015, 35:485-492.
37. Johnson J.J., Syed D.N., Heren C.R., Suh Y., Adhami V.M., Mukhtar H. Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5'-AMP-activated protein kinase (AMPK) pathway. Pharm. Res 2008, 25:2125-2134.
38. Park K.W., Kundu J., Chae I.G., Kim D.H., Yu M.H., Kundu J.K., et al. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells. Int. J. Oncol 2014, 44:1309-1315.
39. Dorrie J., Sapala K., Zunino S.J. Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett 2001, 170:33-39.
40. Al Dhaheri Y., Attoub S., Ramadan G., Arafat K., Bajbouj K., Karuvantevida N., et al. Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer. PLoS ONE 2014, 9:e109630.
41. Cheng A.C., Lee M.F., Tsai M.L., Lai C.S., Lee J.H., Ho C.T., et al. Rosmanol potently induces apoptosis through both the mitochondrial apoptotic pathway and death receptor pathway in human colon adenocarcinoma COLO 205 cells. Food Chem. Toxicol 2011, 49:485-493.
42. Huang S.C., Ho C.T., Lin-Shiau S.Y., Lin J.K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem. Pharmacol 2005, 69:221-232.
43. Vergara D., Simeone P., Bettini S., Tinelli A., Valli L., Storelli C., et al. Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines. Food Func 2014, 5:1261-1269.
44. Lai C.S., Lee J.H., Ho C.T., Liu C.B., Wang J.M., Wang Y.J., et al. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways. J. Agric. Food Chem 2009, 57:10990-10998.
45. Johnson J.J., Syed D.N., Suh Y., Heren C.R., Saleem M., Siddiqui I.A., et al. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev. Res. (Phila.) 2010, 3:1112-1123.
46. Ishida Y., Yamasaki M., Yukizaki C., Nishiyama K., Tsubouchi H., Okayama A., et al. Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis. Hum. Cell 2014, 27:68-77.
47. Chen C.C., Chen H.L., Hsieh C.W., Yang Y.L., Wung B.S. Upregulation of NF-E2-related factor-2-dependent glutathione by carnosol provokes a cytoprotective response and enhances cell survival. Acta Pharmacol. Sin 2011, 32:62-69.
48. Rahnama M., Mahmoudi M., Zamani Taghizadeh Rabe S., Balali-Mood M., Karimi G., Tabasi N., et al. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model. J. Immunotoxicol 2014, 1-8.
49. Manoharan S., Vasanthaselvan M., Silvan S., Baskaran N., Kumar Singh A., Vinoth Kumar V. Carnosic acid: a potent chemopreventive agent against oral carcinogenesis. Chem. Biol. Interact 2010, 188:616-622.
50. Gomez-Garcia F.J., Lopez-Jornet M.P., Alvarez-Sanchez N., Castillo-Sanchez J., Benavente-Garcia O., Vicente Ortega V. Effect of the phenolic compounds apigenin and carnosic acid on oral carcinogenesis in hamster induced by DMBA. Oral Dis 2013, 19:279-286.
51. Sharabani H., Izumchenko E., Wang Q., Kreinin R., Steiner M., Barvish Z., et al. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int. J. Cancer 2006, 118:3012-3021.
52. Moran A.E., Carothers A.M., Weyant M.J., Redston M., Bertagnolli M.M. Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse. Cancer Res 2005, 65:1097-1104.
53. Brieskorn C.H., Fuchs A., B-son Bredenberg J., McChesney J.D., Wenkert E. The structure of carnosol. J. Org. Chem 1964, 29:2293-2298.
54. Johnson J.J. Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett 2011, 305:1-7.
55. Inatani R., Nakatani N., Fuwa H., Seto H. Structure of a new antioxidative phenolic diterpene isolated from rosemary (Rosmarinus officinalis L.). Agric. Biol. Chem 1982, 46:1661-1666.
56. Maeda S., Omata M. Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci 2008, 99:836-842.
57. Lee A.K., Sung S.H., Kim Y.C., Kim S.G. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation. Br. J. Pharmacol 2003, 139:11-20.
58. Balentine C.W., Crandall P.G., O'Bryan C.A., Duong D.Q., Pohlman F.W. The pre- and post-grinding application of rosemary and its effects on lipid oxidation and color during storage of ground beef. Meat Sci 2006, 73:413-421.
59. Mielnik M.B., Aaby K., Skrede G. Commercial antioxidants control lipid oxidation in mechanically deboned turkey meat. Meat Sci 2003, 65:1147-1155.
60. Haak L., Raes K., Smet S.D. Effect of plant phenolics, tocopherol and ascorbic acid on oxidative stability of pork patties. J. Sci. Food Agric 2009, 89:1360-1365.
61. Calvo M.I., Akerreta S., Cavero R.Y. Pharmaceutical ethnobotany in the Riverside of Navarra (Iberian Peninsula). J. Ethnopharmacol 2011, 135:22-33.
62. Sotelo-Felix J.I., Martinez-Fong D., Muriel De la Torre P. Protective effect of carnosol on CCl(4)-induced acute liver damage in rats. Eur. J. Gastroenterol. Hepatol 2002, 14:1001-1006.
63. Offord E.A., Mace K., Ruffieux C., Malnoe A., Pfeifer A.M. Rosemary components inhibit benzo[a]pyrene-induced genotoxicity in human bronchial cells. Carcinogenesis 1995, 16:2057-2062.
64. Jindal A., Agrawal A., Goyal P.K. Influence of Rosemarinus officinalis extract on radiation-induced intestinal injury in mice. J. Environ. Pathol. Toxicol. Oncol 2010, 29:169-179.
65. Sancheti G., Goyal P.K. Prevention of radiation induced hematological alterations by medicinal plant Rosmarinus officinalis, in mice. Afr. J. Tradit. Complement. Altern. Med 2006, 4:165-172.
66. Anadon A., Martinez-Larranaga M.R., Martinez M.A., Ares I., Garcia-Risco M.R., Senorans F.J., et al. Acute oral safety study of rosemary extracts in rats. J. Food Prot 2008, 71:790-795.
67. Aguilar F., Autrup H., Barlow S., Castle L., Crebelli R., Dekrant W., et al. Use of rosemary extracts as a food addtive - scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food. EFSA J. 2008, 721:1-29.
68. Yan H., Wang L., Li X., Yu C., Zhang K., Jiang Y., et al. High-performance liquid chromatography method for determination of carnosic acid in rat plasma and its application to pharmacokinetic study. Biomed. Chromatogr 2009, 23:776-781.
69. Doolaege E.H., Raes K., De Vos F., Verhe R., De Smet S. Absorption, distribution and elimination of carnosic acid, a natural antioxidant from Rosmarinus officinalis, in rats. Plant Foods Hum. Nutr 2011, 66:196-202.
70. Romo Vaquero M., Garcia Villalba R., Larrosa M., Yanez-Gascon M.J., Fromentin E., Flanagan J., et al. Bioavailability of the major bioactive diterpenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Mol. Nutr. Food Res 2013, 57:1834-1846.
71. Ramaiya A., Li G., Petiwala S.M., Johnson J.J. Single dose oral pharmacokinetic profile of alpha-mangostin in mice. Curr. Drug Targets 2012, 13:1698-1704.
72. Petiwala S.M., Li G., Ramaiya A., Kumar A., Gill R.K., Saksena S., et al. Pharmacokinetic characterization of mangosteen (Garcinia mangostana) fruit extract standardized to alpha-mangostin in C57BL/6 mice. Nutr. Res 2014, 34:336-345.
73. Johnson J.J., Bailey H.H., Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010, 17:3-13.
74. Johnson J.J., Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett 2007, 255:170-181.